ANIMAL RESEARCH  T A K E S  LIVES
- Humans and Animals BOTH Suffer

<< previous page | next page >>

contents | index


 

ANTIBIOTICS

ARSL PAGE 3

ARSL 2nd Edition Page 3

 

It is crucial to the joint publishers of Animal Research Saves Lives (all convinced vivisectionists) that the politicians, staff and pupils of educational institutions and the general public, to whom the booklet is distributed, believe and accept its content without question.  However those who are sufficiently inspired or motivated to make their personal investigation will be amply rewarded as a cursory study of the overwhelming and easily-available evidence reveals the truth.

Clinical Medical Discoveries by Dr M. Beddow Bayly, M.R.C.S., L.R.C.P. outlines a brief history of the discovery and application, by human observations, of antibiotic penicillin until the advent of Prof. A. Fleming and Sir Howard Florey, who carried out all their initial experiments in vitro.  More recently Dr Robert Sharpe, basing his article on Clinical Pharmacology and Therapeutics by T. Koppanyi and M.A. Avery, Vol. 7, 1966, pages 250-270, agreed with a report made by Hans Ruesch in Naked Empress (or the Great Medical Fraud) that Fleming, being worried that penicillin might be de-activated by blood, injected a sample into rabbits, which died.  Discouraged he abandoned penicillin until Oxford scientists Florey and Chain resurrected it for further tests.  Being out of stock of the usual guinea-pigs on the day of the trials they used mice which it cured and penicillin was acclaimed.  Later trials with guinea-pigs proved fatal, even with tiny amounts.  Another coincidence occurred when Fleming was reluctant to inject penicillin into the spine of a critically-ill patient and Florey tried it on cats.  As the patient was near death with insufficient time to observe the cats Fleming took a gamble and administered the penicillin.  The patient lived and the cats died.  Thus humans received penicillin despite the erroneous and inconclusive trials with animals which almost resulted in its rejection and abandonment.

Despite its apparent success, evidence shows that the discovery of antibiotics might have been a devil in disguise.  In Slaughter of the Innocent Hans Ruesch reveals reports from many doctors and medical institutions warning that antibiotics weaken the organisms while strengthening the various strains of bacteria to such an extent that some of them eventually defy every type of antibiotic.

Ruesch points out that by the end of the 1940s antibiotics were so overprescribed that the result was the production of stronger and stronger bacteria, and weaker and weaker human beings.  By the 1950s various hospitals registered outbreaks of epidemics that no antibiotic was able to cure.  Brian Inglis reported that in the U.S. there were "over a hundred such epidemics in a single year, of which one killed 22 patients in a Texas hospital".  When the medical authorities argued that the use of antibiotics was justified in spite of the recognised damage, John Lear, former science editor of the Saturday Review wrote in a "miracle drugs" article about a study made by Charles Henry Kempe, University of Chicago medical researcher, as follows:

"The record shows that prophylactic antibiotics do more harm than good.  Dr Kempe's study cited in this connection the result of a 250 'clean' operation.  Of the 154 not subjected to prophylactic antibiotics only 7.8% developed bacterial aftermath.  The remaining 96 patients all received prophylactic antibiotics, of which 37.5% were subjected to bacterial complications."


In December 1972, Dr Harry F. Dowling, Professor Emeritus at the University of Illinois and former Chairman of the Council on Drugs of the American Medical Association testified before the Senate Monopoly Subcommittee:

"A few years ago we were resting secure in the knowledge that we had two effective drugs for use in typhoid fever: chloramphenicol and ampicillin.  Then a strain of typhoid bacilli was found that was resistant to chloramphenicol, and now one is resistant to ampicillin.  Before too long we may be back to the 1930s when we had no effective therapy for this disease."


On December 9 1972 the International Herald Tribune reported:

"Resistant bacteria are increasing blood poisoning in hospital patients treated with antibiotics."


In Rome's Il Tempo, July 31 1976 Nobel Laureate James Banielli stated that "antibiotics have caused damages that are far superior to their benefits", having been found responsible for chronic conditions, for specific injections, for allergic reactions, cellular toxicity and vitamin deficiencies.


In Animal Factories, Jim Mason and Peter Singer expose the danger of antibiotics used in the agribusiness - and how the pharmaceutical companies now own many of the factory farms:

"Crowding masses of animals together causes stress, germ build-up, filthy air, and other conditions that invite disease.  To cope with these diseases farmers must employ antibiotics, sulfa drugs, pesticides, disinfectants and a whole battery of other chemical products.  Food from animals raised in such an environment is not only of poor quality but it can also contain chemical residues that are dangerous to humans."

"The US Food and Drug Administration's efforts to ban or regulate antibiotics, growth promotants and other feed additives in animal agriculture are vigorously opposed by drug and agribusiness corporations since

  1. many factory farms are owned by the drug companies
  2. and
  3. without these artificial and erroneous shortcuts to animal health the losses in crowded factory farms would be so great that the system would be impossible, much less profitable."


For the prevention of infection in pets after injury or accident refer Chapter 2, The Farming Industry, Animal Health and Vaccines.  Chapter 3 Diseases in Cats and Dogs, Feline Enteritis, Distemper; Cats and Dogs Vaccines, Parvovirus also refer:

"We have to remember that the main aim of pharmaceutical companies is not to make drugs for the good of mankind, but to make profits for their shareholders."
(Brewster Ashley, Director of the Therapeutic Goods Administration, Drug Evaluation Branch (Australia) in Auckland Star, March 7 1991, page 7 under World News.)

 

<< previous page | next page >>

contents | index